Trials / Unknown
UnknownNCT05792696
PPI Guided Strategies for Prevention and Treatment of Intraoperative Hypotension
Effectiveness of Peripheral Perfusion Index Guided Strategies for the Prevention and Treatment of Hypotension: a Randomized Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- zhiqiang zhou · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
Intraoperative hypotension is closely related to the poor prognosis of surgery. The study is focused on the effectiveness of maintaining normal peripheral perfusion index (PPI) on time-weighted average of hypotension during anesthesia.
Detailed description
Intraoperative hypotension is closely related to the poor prognosis of surgery. Hypotension decreased blood flow perfusion of organs, which lead to dysfunction of multiple organs, especially increasing serious complications such as cardio-cerebrovascular events and acute renal injury within 30 days after surgery. The aim of this study is to establish a set of strategies that can effectively prevent and treat intraoperative hypotension, so as to alleviate possible harm to patients from perioperative hypotension. The study is focused on the effectiveness of maintaining normal peripheral perfusion index (PPI) on time-weighted average of hypotension during anesthesia. The lower target mean arterial pressure (MAP) was higher than 65 mmHg. MAP less than 65 mmHg was defined as intraoperative hypotension between induction and tracheal extubation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | PPI guided strategies | For targeted MAP or lower, if PPI\<1, more fluid therapy. if PPI\>3, vasoconstriction therapy. For MAP\<65mmHg and 1\<=PPI\<3, test bolus of 250 ml crystalloid fluid. |
| BEHAVIORAL | Empirical strategies | Fluid therapy or vasoconstriction depended on experiences of anesthetic staffs. |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2025-06-30
- Completion
- 2025-06-30
- First posted
- 2023-03-31
- Last updated
- 2024-10-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05792696. Inclusion in this directory is not an endorsement.